| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |